Form D · Biotechnology

THERMALIN INC.

Waban, MA · CIK 0001715535

Offering snapshot reported Aug 22, 2019 · SEC filing

Reported sold: $17.1M
Investors reported: 6
Minimum accepted: $0
First sale: Jul 7, 2017

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$4,896,461 → $17,121,564
Reported investors4 → 6

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 22, 2019	Amendment	$17,121,564	$12,225,103vs Nov 24, 2017	6	SEC filing
Aug 8, 2019	Initial	$2,337,021	No comparison	5	SEC filing
Nov 24, 2017	Initial	$4,896,461	No comparison	4	SEC filing

Offering details

Securities: Equity, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $367K (estimated)
Finders' fees: $0
Form D file number: 021-299446

Series A Preferred

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
None	None	BOSTON INNOVATION CAPITAL, LLC · CRD 268813

Source: Form D, filed Aug 22, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Richard Berenson	Director, Executive, Promoter
Katherine Bowdish	Director
John Brooks	Director
Masako Hashimoto	Director
John Picerne	Director
David C. Sweeney	Director
Tim Xiao	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

39 Karen Road
Waban, MA, 02468